Epilepsy and Seizure News
Seizure action plans: Management and educational tools in epilepsy care -
Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters. Neurology ...
Using Seizure-Risk Forecasts to ID Best Time for Epilepsy Monitoring -
NASHVILLE, Tennessee ― Scheduling video-electroencephalography (vEEG) monitoring on the basis of personalized seizure risk forecasts may improve diagnostic accuracy, emerging research suggests. In a ...
Seizure Burden in Resistant Epilepsy May Ease With the Tincture of Time -
Nearly 70% of patients with focal treatment-resistant epilepsy (FTRE) experience fewer seizures over time, new results of a multicenter study showed. However, the improvements occurred independent of ...
Epilepsy Caregiver Support: 5 Resources Every Family Should Know About -
Epilepsy Foundation offers support for caregivers through SAGE, Epilepsy & Seizures Helpline, local services, and more. Navigate epilepsy with less stress.
Seizure or epilepsy? Understanding the critical difference could save lives -
A sudden episode of shaking, confusion, or loss of awareness can be frightening - but does it mean epilepsy? Understanding the difference between a seizure and epilepsy is crucial for timely treatment ...
Focal treatment-resistant epilepsy symptoms improved with antiseizure medication -
Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...
NEURELIS PRESENTS STUDIES ON SEIZURE CLUSTERS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING -
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
Does Levetiracetam Improve Seizure Outcomes in Pediatric Epilepsy? -
Although levetiracetam was associated with improved seizure outcomes compared with placebo in pediatric epilepsy, it did not demonstrate superior efficacy when compared with established active ...
The brain has its own thermostat. A study shows epilepsy may interfere with it -
Doctors have long known that changes in body temperature can affect seizure activity. Fever can trigger seizures in some young children, while in rare forms of epilepsy, bathing in hot water can bring ...
Neurofeedback News
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
What Is Neurofeedback? -
Whenever I mention that neurofeedback helped me regain my life after my multiple brain injuries — or that I’m now a neurofeedback provider — the first reaction is to ask me, what is neurofeedback? I’m ...
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
Neurofeedback Gains Popularity and Lab Attention -
You sit in a chair, facing a computer screen, while a clinician sticks electrodes to your scalp with a viscous goop that takes days to wash out of your hair. Wires from the sensors connect to a ...
Medical News Today
PubMed
Artificial intelligence models for automated and semiautomated analysis and interpretation of clinical electroencephalography -
Electroencephalography is the most commonly used diagnostic tool for epilepsy. However, interpreting electroencephalograms (EEGs) requires expertise that is not widely available. Advances in digital technology and wearables have enabled large-scale EEG recording, generating vast amounts of data that cannot be managed through traditional visual interpretation by experts. Artificial intelligence ...
Status, challenges, and future directions of machine learning in the management of epilepsy: a systematic review and meta-analysis -
BACKGROUND: Despite advances in epilepsy treatment options, selecting the appropriate therapy for an individual with epilepsy is a process of trial and error. Machine learning holds the potential to support clinical decision making. We aimed to provide an overview of the role of machine learning in epilepsy management and discuss future directions.
Machine learning prediction for epilepsy treatment selection and prognosis: achievements and challenges -
Accurate prediction of treatment response and selection of optimal treatments remain challenging in epilepsy management. With no reliable surrogate biomarkers for treatment response, the current process of selecting an antiseizure medication remains largely a trial-and-error approach. Other non-pharmacological treatment options, such as epilepsy surgery, are viable alternatives for patients wit...
Magnetoencephalography Source Analysis in Epilepsy-Aphasia Spectrum -
CONCLUSIONS: This first systematic MEG source analysis across the full EAS reveals a hierarchical gradient from temporo-centric to fronto-centric distribution, paralleling the clinical severity gradient. Our findings highlight the potential of MEG source imaging for phenotyping and pathophysiological stratification in EAS.
Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study -
BACKGROUND: As individuals with Down syndrome age, they face high risks of Alzheimer's disease and epilepsy. With symptomatic Alzheimer's disease, late-onset myoclonic epilepsy in Down syndrome (LOMEDS) often emerges. We aimed to examine how epilepsy develops in Down syndrome, its timing relative to Alzheimer's disease symptom onset, and its effect on prognosis.
Plasma levels of glial fibrillary acidic protein and placental growth factor are associated with drug resistance in adult patients with newly diagnosed epilepsy -
CONCLUSION: Our findings suggest plasma GFAP and PGF may be associated with drug resistance in adult patients with newly diagnosed epilepsy.
Science Daily